Investigation of factors influencing radioiodine (131 I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach

European Journal of Clinical Pharmacology
Valentina Topić VučenovićKatarina Vučićević

Abstract

Radioiodine (131I) therapy is the common treatment option for benign thyroid diseases. The objective of this study was to characterize 131I biokinetics in patients with benign thyroid disease and to investigate and quantify the influence of patients' demographic and clinical characteristics on intra-thyroidal 131I kinetics by developing a population model. Population pharmacokinetic analysis was performed using a nonlinear mixed effects approach. Data sets of 345 adult patients with benign thyroid disease, retrospectively collected from patients' medical records, were evaluated in the analysis. The two-compartment model of 131I biokinetics representing the blood compartment and thyroid gland was used as the structural model. Results of the study indicate that the rate constant of the uptake of 131I into the thyroid (ktu) is significantly influenced by clinical diagnosis, age, functional thyroid volume, free thyroxine in plasma (fT4), use of anti-thyroid drugs, and time of discontinuation of therapy before administration of the radioiodine (THDT), while the effective half-life of 131I is affected by the age of the patients. Inclusion of the covariates in the base model resulted in a decrease of the between subject variability fo...Continue Reading

References

Dec 1, 1966·The Journal of Clinical Endocrinology and Metabolism·T H OddieD A Fisher
May 1, 1993·Computer Methods and Programs in Biomedicine·Y MerléA Aurengo
Dec 1, 1995·Endocrine Reviews·S MariottiA Pinchera
Apr 13, 1999·The Journal of Clinical Endocrinology and Metabolism·O SabriU Buell
Mar 28, 2002·Thyroid : Official Journal of the American Thyroid Association·Milena BragaDavid S Cooper
Aug 23, 2002·European Journal of Nuclear Medicine and Molecular Imaging·D MokaH Schicha
Aug 23, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Michael J ReinhardtThomas M Krause
Mar 1, 1960·The American Journal of Medicine·R R GRAYSON
Mar 22, 2005·Cancer Biotherapy & Radiopharmaceuticals·Johan ArebergS Mattsson
Jun 1, 2006·The Journal of Clinical Endocrinology and Metabolism·Steen Joop BonnemaLaszlo Hegedüs
Oct 6, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Simone DunkelmannCarl Schuemichen
Jun 9, 2007·Journal of Endocrinological Investigation·F MassaroM Giusti
Mar 5, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wesley E BolchStephen R Thomas
Aug 4, 2009·The AAPS Journal·Radojka M Savic, Mats O Karlsson
Jul 14, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Marcel P M StokkelMarkus Luster
Dec 18, 2010·Thyroid : Official Journal of the American Thyroid Association·Eveline Predebon MorschHelena Schmid
May 3, 2011·Zeitschrift für medizinische Physik·Heribert HänscheidChristoph Reiners
Jul 13, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Edward B SilbersteinAlan D Waxman
Jul 10, 2013·CPT: Pharmacometrics & Systems Pharmacology·R J KeizerA Hooker
Jul 23, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Steen Joop BonnemaLaszlo Hegedüs
Aug 27, 2014·Annales d'endocrinologie·Delphine BernardDaniel Fagret
Apr 14, 2015·The Journal of Clinical Endocrinology and Metabolism·Aglaia KyrilliRodrigo Moreno-Reyes
Oct 2, 2015·Nuclear Medicine Communications·Seyed R ZakaviZohreh Moosavi
Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Nov 25, 2016·CPT: Pharmacometrics & Systems Pharmacology·T H T NguyenUNKNOWN Model Evaluation Group of the International Society of Pharmacometrics (ISoP) Best Practice Committee
Dec 7, 2016·Nuklearmedizin. Nuclear Medicine·Markus DietleinMarkus Luster

❮ Previous
Next ❯

Citations

Jul 15, 2021·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Jan TaproggeGlenn D Flux

❮ Previous
Next ❯

Software Mentioned

NONMEM®
Perl
Xpose®
Pirana®

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.